Vaccines List

ACI-35.030 is a first-in-class vaccine candidate designed to generate a specific antibody response against pTau proteins in the brain.Read more...

Ad26.Mos4.HIV is a tetravalent vaccine candidate containing recombinant adenovirus serotype 26 (Ad26) vectors with mosaic inserts.Read more...

Ad5-EBOV is an adenovirus type 5 vector-based Ebola virus disease vaccine that protects against Ebola virus disease.Read more...

Adacel vaccine contains noninfectious tetanus, diphtheria, and pertussis proteins.Read more...

Afluria Quadrivalent is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B.Read more...

AGI-134 is a synthetic molecule that by intratumoral injection triggers a systemic anti-tumor response.Read more...

ASP3772 utilizes the Multiple Antigen Presenting System (MAPS) platform which uniquely presents key epitopes of the desired antigens (polysaccharides and/or proteins) to induce a robust and broad immune response against challenging diseases.Read more...

ATX-GD-59 is a candidate for potential treatment to target the immunological basis of Graves' disease.Read more...

Avigan (favipiravir) is an antiviral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses.Read more...

Bacille Calmette-Guerin (BCG) vaccine is an attenuated, live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis.Read more...

Baricitinib is a Janus kinase inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation. It is FDA approved to treat RA and Authorized in combination with remdesivir (Veklury) to treat COVID-19Read more...

BBV154 is an intranasal vaccine that stimulates a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses.Read more...

Bexsero contains different proteins taken from group B Neisseria meningitidis bacteria. The combination of proteins was chosen to protect against the majority of MenB strains. They are also expected to protect against other types of meningococcal bacteria, including MenW.Read more...

BioThrax, Anthrax Vaccine Adsorbed, is made from cell-free filtrates of microaerophilic cultures of an avirulent, nonencapsulated strain of Bacillus anthracis.Read more...

BPZE1 is an intranasal vaccine candidate that consists of a live, attenuated form of the pertussis bacterium.Read more...

Brilife is a recombinant vesicular stomatitis virus (VSV), an animal virus that does not cause disease in humans, and where the spike protein was replaced with that of SARS-CoV-2Read more...

Cervarix vaccine is a non-infectious recombinant, AS04-adjuvanted vaccine, that contains recombinant L1 protein, the major antigenic protein of the capsid, of oncogenic HPV types 16 and 18. Read more...

ChiroRab is an inactivated rabies virus of the strain Flury LEP, produced in India.Read more...

CoraVax utilizes the spike protein component of the SARS-CoV-2 virus.Read more...

Covaxin (BBV152) is an inactivated COVID-19 Vaccine candidate. The SARS-CoV-2 virus strain was isolated from an asymptomatic COVID-19 patient at NIV, Pune. Read more...

COVI-VAC COVID-19 is a single-dose intranasal, live-attenuated vaccine candidate that is generated using Codagenix’s proprietary deoptimization technology.Read more...

S-Trimer COVID-19  Vaccine (SCB-2019)  was developed by Clover Biopharma combining the trimeric SARS-CoV-2 spike (S)-protein with the company’s proprietary Trimer-Tag technology.Read more...

CoviVac-Russia COVID-19 Vaccine is a Whole-virion vaccine that uses viruses that have already been killed (inactivated).Read more...

CRV-101 is a next-generation vaccine designed to maximize the CMI protection by combining the gE protein antigen with our proprietary adjuvant produced by Curevo.Read more...

CVnCoV is an mRNA vaccine candidate that utilizes nucleotides without chemical modifications in the mRNA.Read more...

Daptacel is a combination vaccine that helps prevent diphtheria, tetanus, and pertussis. Diphtheria, tetanus, and pertussis are serious diseases caused by bacteriaRead more...

Dengvaxia is a vaccine that prevents dengue infection due to dengue virus serotypes 1, 2, 3, and 4.Read more...

Diamyd® is an antigen-specific immunotherapy for the preservation of endogenous insulin production. Read more...

Ebanga (mAb114) (Ansuvimab) is a human IgG1 MAb targeted to the Zaire ebolavirus glycoprotein (GP).  Ebanga is a single monoclonal antibody that binds to the core receptor binding domain of the Zaire ebolavirus surface protein, preventing the virus from infecting human cells.Read more...

Encepur is a vaccine that consists of an inactivated and purified Tick-Borne Encephalitis (TBE) virus/strainRead more...

eOD-GT8 60mer HIV Vaccine candidate is designed to stimulate rare immune cells with specific properties. Read more...

Ervebo (rVSV-ZEBOV-GP) (v920) is a recombinant, replication-competent Ebola vaccine, consisting of a vesicular stomatitis virus (VSV), which has been genetically engineered to express a glycoprotein from the Zaire ebolavirus so as to provoke a neutralizing immune response to the Ebola virus.Read more...

EXD-12 is a live attenuated vaccine candidate being researched and developed to prevent and treat the Herpes Simplex Virus.Read more...

Fluad consists of an inactivated, trivalent influenza virus antigen produced in eggs and an oil-in-water emulsion adjuvant, MF59C.1.Read more...

Fluarix Quadrivalent is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.Read more...

Flucelvax Quadrivalent is a cell culture-based flu vaccine to help offer protection against 4 flu virus strains identified for the current flu season.Read more...

FluMist Quadrivalent is an Intranasal vaccine that is a live quadrivalent vaccine that is formulated to contain four vaccine virus strains.Read more...

Gardasil vaccine consists of 4 proteins of HPV types 6, 11, 16, and 18, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water.Read more...

GBS6 is a multivalent group B streptococcus vaccine candidateRead more...

GEN-009 is an investigational, personalized adjuvanted vaccine, that is being developed for the treatment of patients with solid tumors.Read more...

GEO-LM01 is a vaccine candidate that is based on the Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform, which generates noninfectious VLPs in the individual being vaccinatedRead more...

GOVX-B11 is a vaccine candidate that uses recombinant DNA and recombinant modified vaccinia Ankara (MVA) vaccines to express non-infectious virus-like particles. Read more...

HB-201 Monotherapy to treat HPV16+ cancers is based on HOOKIPA's proprietary arenavirus platform.Read more...

Hecolin is a recombinant vaccine which contains the hepatitis E virus (HEV)-like particles prepared using a recombinant Escherichia coli expression systemRead more...

Heplisav-B vaccine combines hepatitis B surface antigen with Dynavax's proprietary Toll-like Receptor (TLR), 9 agonist, to enhance the immune response.Read more...

Herpes simplex virus (HSV) vaccine development has been an ongoing challenge for decades.Read more...

The herpes simplex virus type 2 (HSV-2) vaccine candidate (GSK4108771A) utilizes self-amplifying messenger RNA, "SAM" technology. Read more...

HydroVax-001 is a vaccine candidate that consists of a hydrogen peroxide inactivated, whole virion (WNV-Kunjin strain) adjuvanted with aluminum hydroxide.Read more...

Imovax Rabies is an inactivated vaccine made from an attenuated rabies virus. It is a sterile, stable, freeze-dried suspension of Rabies Vaccine Inactivated virus prepared from WISTAR Rabies PM/WI 38 1503-3M strain.Read more...

Influenza vaccines, known as flu shots, protect people against the influenza viruses that research indicates will be most common during the upcoming season. Read more...

INO-3107 is a DNA medicine being evaluated for the treatment of recurrent respiratory papillomatosis.Read more...

INO-4700 is a DNA plasmid vaccine candidate that expresses the MERS CoV spike (S) glycoprotein.Read more...

INO-A002 is a DNA-encoded monoclonal antibody (dMAb™) technology candidate.Read more...

IVX-121 an RSV vaccine candidate incorporates a stabilized prefusion F antigen licensed from NIAID/NIHRead more...

COVID-19 Janssen vaccine candidate is an adenovirus serotype 26 (Ad26) vector-based vaccine that elicits a robust immune response as demonstrated by neutralizing antibodiesRead more...

JYNNEOS smallpox vaccine is based on a live, attenuated vaccinia virus (Modified Vaccinia Ankara, MVA-BN), incapable of replicating in the body, yet still capable of eliciting a potent immune response.Read more...

Vyrologix (Leronlimab, PRO 140) is a drug candidate that is a CCR5 antagonist with the potential for multiple therapeutic indications including COVID-19Read more...

M-001 vaccine is a recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses.Read more...

M72/AS01E is a subunit vaccine candidate comprised of an immunogenic fusion protein (M72) derived from two Mycobacterium tuberculosis (M.tb) antigens (MTB32A and MTB39A), and the GlaxoSmithKline proprietary adjuvant AS01E.Read more...

Menactra contains N meningitidis serogroup 8 A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid 9 protein. N meningitidis A, C, Y, and W-135 strains are cultured on Mueller Hinton agar and 10 grown in Watson Scherp media containing casamino acid.Read more...

Menveo consists of two portions: 10 µg of lyophilized meningococcal serogroup A capsular polysaccharide conjugated to CRM197 and 5 μg each of capsular polysaccharide of serogroup C, W, and Y conjugated to CRM197 in 0.5 mL of phosphate-buffered saline, which is used to reconstitute the lyophilized MenA component.Read more...

Metablok is a novel peptide drug candidate for treating inflammation in the lungs, liver, and kidneys. Read more...

COVID-19 Vaccine Moderna is an mRNA vaccine candidate targeting the novel coronavirus SARS-CoV-2 encoding for a prefusion stabilized form of the Spike (S) protein.Read more...

mRNA-1647 is designed to produce an immune response to both pentamer and gB antigens to prevent CMV infection.Read more...

mRNA-1893 contains an mRNA sequence encoding for the structural proteins of the Zika virus and is designed to cause cells to secrete virus-like particles, mimicking the response of the cell after natural infection.Read more...

Moderna's mRNA-4157 is a therapeutic cancer vaccine candidate that is a combination of validated defined neoantigens, predicted neoepitopes, and mutations in driver genes into a single mRNA concatemer (mRNA-4650).Read more...

MV-LASV vaccine candidate is a recombinant, live-attenuated, viral vectored vaccine, based on the backbone of the measles Schwarz virus strain for prophylaxis of Lassa infectionRead more...

MVA-BN WEV is a prophylactic vaccine candidate against three equine encephalitis viruses (western, eastern and Venezuelan.Read more...

MVA-M1+NP vaccine candidate consists of MVA, a replication-deficient pox viral vector that has been safely tested in thousands of patients, to generate a strong immune reaction against Matrix 1 (M1) and Nucleoprotein (NP) influenza antigens. Read more...

NanoFlu is an influenza vaccine candidate which is a recombinant hemagglutinin protein nanoparticle influenza vaccine produced in an Sf9 insect cell-baculovirus system.Read more...

NasoVAX is a recombinant intranasal vaccine that is RD-Ad5-based, being developed for both seasonal and pandemic use, possibly including COVID-19.Read more...

NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.Read more...

Nimenrix is indicated for the active immunization of individuals from 6 weeks to 55 years of age against invasive meningococcal diseases caused by Neisseria meningitidis serogroups A, C, W-135 and Y.Read more...

nOPV2 Polio Vaccine candidate is derived from the live, infectious virus — but this time it has been ‘triple-locked’ using genetic engineering, to prevent it from becoming harmfulRead more...

NVX-CoV2372 (Covovax) is a stable, prefusion protein COVID-19 coronavirus vaccine candidate made using Novavax’s proprietary nanoparticle technology. NVX-CoV2372 is currently in several ongoing clinical trials.Read more...

Orimune is a liquid oral poliovirus vaccine (OPV) that is taken by mouth to help prevent polio infection. Orimune contains live attenuated Sabin strain types 1,2, and 3.Read more...

Pamvac is a vaccine candidate based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA).Read more...

PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age.Read more...

Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component as well as an ActHIB® vaccine component Read more...

PF-07321332 is an Anti-Viral Therapeutic targeting the SARS-CoV-2 virus.  PF-07321332 is a protease inhibitor that has demonstrated potent in vitro anti-viral activityRead more...

BioNTech and Pfizer COVID-19 Vaccine (Comirnaty) (Tozinameran) (BNT162b2) is an mRNA-based vaccine that prevents severe COVID-19 disease.Read more...

PIpepTolDC is an investigational vaccine that uses a person’s own immune cells, a beta cell protein and vitamin D3 to potentially treat type 1 diabetesRead more...

Plaquenil (hydroxychloroquine) is used to prevent or treat malaria, and for certain rheumatoid arthritis, systemic lupus erythematosus, and porphyria cutanea trade therapies.Read more...

Pneumosil is indicated against invasive disease, pneumonia, and acute otitis media caused by 10 Streptococcus pneumoniae serotypes in infants and toddlers from 6 weeks up to 2 years of age.Read more...

PolyPEPI1018 an investigational off-the-shelf vaccine for colorectal cancerRead more...

Priorix is a vaccine to protect against measles, mumps, and rubella. Priorix is currently licensed outside the USA in over 100 countries. Priorix-TETRA includes protection for measles, mumps, rubella, and varicella.Read more...

ProscaVax vaccine incorporates scientifically proven and clinically validated treatments for cancer.Read more...

PRV-101 is a polyvalent coxsackievirus B (CVB) vaccine licensed from Vactech, Ltd., which Provention is developing as a potential vaccine for acute coxsackie infection and for the potential prevention of up to 50% of worldwide type 1 diabetes (T1D) cases.Read more...

Quadracel is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis.Read more...

RabAvert is a vaccine that contains an inactivated rabies antigen.Read more...

RAPIVAB (peramivir injection) is an influenza virus neuraminidase inhibitor.Read more...

Redeeflu is a nasal vaccine candidate utilizing a proprietary M2 deleted, single replication (M2SR) influenza virus.Read more...

ResVax is a vaccine candidate composed of recombinant RSV F nanoparticles adsorbed to aluminum phosphate. The F protein is essential to RSV infectivity and is the target of palivizumab.Read more...

RiVax Ricin Toxin Vaccine is Soligenix's proprietary heat stable recombinant subunit vaccine developed to protect against exposure to ricin toxin.Read more...

RotaTeq is a live, oral pentavalent vaccine that contains 5 reassortant viruses.Read more...

RSVpreF vaccine candidate is based on the prefusion form of the RSV fusion protein, aided by the discovery of the crystal structure of key viral proteins by the National Institutes of Health.Read more...

RV144 is an HIV vaccine candidate that combines two different vaccine types: a prime and a booster.Read more...

The Sanofi - GSK vaccine candidate combines innovative technologies to produce an adjuvanted recombinant protein-based COVID-19 vaccine.Read more...

Sci-B-Vac is a licensed, third-generation hepatitis B  trivalent vaccine which mimics all three surface antigens, pre-S1, pre-S2, and S, of the hepatitis B virus (“HBV”).Read more...

scMAYV-E is a novel DNA vaccine that encodes a synthetically-designed consensus MAYV envelope sequence.Read more...

Shingrix is an adjuvanted recombinant zoster vaccine, consisting of the varicella-zoster virus glycoprotein E antigen and the AS01B adjuvant system, and a proprietary adjuvant containing QS-21 and MPL with liposomes.Read more...

Sinovac's PPV23 Pneumococcal Vaccine consists of 23 pneumococcal serotypes that are most frequently found in China.Read more...

Cuba Soberana 02 COVID-19 vaccine candidate (FINLAY-FR-2) is a conjugate vaccine, in which the virus antigen, the receptor-binding domain (RBD), is chemically bound to the tetanus toxoidRead more...

The Sputnik V vaccine (Gam-COVID-Vac) uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.Read more...

SurVaxM is a peptide mimic immunotherapeutic vaccine (immunotherapy) that targets survivin, a cell-survival protein present in 95 percent of glioblastomas and many other cancers.Read more...

TAK-214 a vaccine candidate uses virus-like particle (VLP) antigens, which are proteins that precisely mimic the outer surface of norovirus. The vaccine includes antigens from genotypes GI.1 and GII.4, to represent both of the genogroups that cause the majority of human illness.Read more...

TetraVax-DV-TV003 is a live attenuated recombinant tetravalent dengue vaccine.Read more...

TG4050 is an individualized therapeutic vaccine designed to stimulate and educate the immune system of patients to recognize and destroy tumor cells. Read more...

UK marketing authorization was granted for Sanofi Pasteur’s Trivalent Influenza Vaccine High Dose. TIV High Dose is approved for the prevention of influenza in people 65 years of age and older,1 a population that is particularly vulnerable to influenza infection and its complications2Read more...

TMCP2 is a vaccine candidate to treat Gonorrhea. It is a complex peptide that is both scalable and economically produced to a high degree of purity.Read more...

Trumenba is a sterile suspension composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily A and one from subfamily B (A05 and B01, respectively).Read more...

TY014 will be the first therapeutic vaccine specifically targeting the Yellow Fever Virus to enter clinical trials. It is anticipated that a monoclonal antibody therapeutic could be administered to infected cases to reduce disease severity within the patient and their contacts.Read more...

Typhim VI protects against the risk of infection related to Salmonella typh i but it does not confer vis-à-vis protection of Salmonella Paratyphi A or B, or non-typhoid salmonella.Read more...

The UB-612 COVAXX vaccine is designed to target a critical antigen from the S protein (Receptor Binding Domain, RBD) thought to be necessary for viral attachment to human cells plus additional viral epitopes (from other viral structural proteins) designed to promote B-cell and CD8+ T-cell memory responses. Read more...

UV1 is a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase.Read more...

V180 is inactivated, containing only the truncated form of the structural envelope protein, which prevents serotypes from interfering with each other.Read more...

Vaqta is an inactivated whole virus vaccine derived from hepatitis A virus grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain.Read more...

Vaxart VXA-CoV2-1 is an oral tablet vaccine targeting both the spike protein (S) and nucleoprotein (N) of the novel SARS-CoV-2 coronavirus.Read more...

Vaxelis is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...

VBI-1901 is a cancer vaccine that VBI Vaccines has designed to treat glioblastoma multiforme and medulloblastoma, two types of brain tumors.Read more...

VC2 vaccine candidate is a live-attenuated, engineered version of HSV-1. The VC2 vaccine targets facial, ocular, and genital herpes caused by HSV-1 but may also protect against genital herpes caused by HSV-2. Read more...

Veklury (Remdesivir) is a nucleotide analog with broad-spectrum antiviral activity both in vitro and in vivo models against multiple emerging viral pathogens.Read more...

VIR-1111 HIV vaccine canidate is based on human cytomegalovirus that has been designed to elicit abundant T cells that recognize HIV epitopes in a way that differs from prior HIV vaccines.Read more...

Vitagerpavac is the only multivalent vaccine in the world for the treatment of chronic herpesvirus infection (HCV) of types I and IIRead more...

VLA15 is a multivalent Lyme Disease vaccine candidate targeting the outer surface protein A (OspA) of Borrelia. It is designed for prophylactic, active immunization against Lyme disease aiming for protection against the majority of human pathogenic Borrelia species.Read more...

VLA1601 is a purified, inactivated, whole Zika virus (ZIKV) vaccine candidate adsorbed on aluminum hydroxide (alum).Read more...

VPM1002  is a genetically modified BCG vaccine derived from the Mycobacterium bovis BCG subtype Prague characterized as rBCGÄureC::Hly+. Read more...

VRC5283 is a Zika Virus DNA Vaccine candidate.  It is composed of a single closed-circular DNA plasmid that encodes with wild type precursor transmembrane M and envelope proteins from the H/PF/2013 strain of ZIKV.Read more...

VXA-G1.1-NN is an Oral Vaccine Candidate Tablet addressing Norovirus.Read more...

YF-VAX is prepared by culturing the 17D-204 strain of yellow fever virus in living avian leukosis virus-free chicken embryos. The vaccine contains sorbitol and gelatin as a stabilizer, is lyophilized, and is hermetically sealed under nitrogen.Read more...

ZF2001 is a protein subunit vaccine using a dimeric form of the receptor-binding domain (RBD) as the antigen, a harmless piece of the SARS-Cov-2 virus. Read more...

ZPIV is a Zika virus vaccine candidate which consists of a purified formalin-inactivated Zika virus.Read more...